LeukocytosisSymptoms, Doctors, Treatments, Advances & More
Learn About Leukocytosis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Advocate Good Samaritan Cancer Center
Katy Goldsborough is a Hematologist and an Oncologist practicing medicine in Downers Grove, Illinois. Dr. Goldsborough is rated as a Distinguished provider by MediFind in the treatment of Leukocytosis. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Leukocytosis, Paget Disease of the Breast, and Pleuropulmonary Blastoma. Dr. Goldsborough is board certified in American Board Of Internal Medicine, Hematology.
Avera Medical Group Oncology & Hematology — Aberdeen
Dr. Richard Conklin is an oncologist/hematologist at Avera Medical Group Oncology & Hematology Aberdeen. Dr. Conklin is rated as a Distinguished provider by MediFind in the treatment of Leukocytosis. He is also highly rated in 90 other conditions, according to our data. His clinical expertise encompasses Acute Myelomonocytic Leukemia, Familial Colorectal Cancer, Lynch Syndrome, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Conklin is board certified in American Board Of Internal Medicine American Board Of Internal Medicine-Medical Oncology.
Bassett Cancer Institute At FoxCare
Sara Parylo is a Hematologist practicing medicine in Oneonta, New York. Dr. Parylo is rated as an Advanced provider by MediFind in the treatment of Leukocytosis. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Leukocytosis, and Small Cell Lung Cancer (SCLC). Dr. Parylo is board certified in American Board Of Internal Medicine.
Summary: The LALGFA2019 Recommendations redefine the standard risk criteria and propose to introduce anthracycline induction in so-called high-risk forms (LAL line T and LAL line B with leukocytosis greater than or equal to 50 G/L or in children less than 1 year of age or more than 10 years of age) as well as Endoxan and Methotrexate in high dose consolidation.
Summary: In Slovenia, tick-borne encephalitis and Lyme borreliosis are both endemic diseases with high incidence rates and they are both transmitted by a bite of infected Ixodes ricinus tick. In clinical practice, tick-borne encephalitis is confirmed by demonstration of tick-borne encephalitis antibodies in serum of a patient with compatible clinical presentation and cerebrospinal pleocytosis. Patients wit...